S&T Bank Myriad Genetics Inc Transaction History

S&T Bank

  • $308 Million
  • Q4 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$22.67 - $28.01 $339,301 - $419,225
-14,967 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$24.13 - $32.63 $83,393 - $112,769
-3,456 Reduced 18.76%
14,967 $413,000
Q3 2021

Nov 12, 2021
SELL
$29.97 - $36.66 $579,589 - $708,967
-19,339 Reduced 51.21%
18,423 $595,000
Q2 2021

Aug 13, 2021
SELL
$25.39 - $32.61 $147,998 - $190,083
-5,829 Reduced 13.37%
37,762 $1.16 Million
Q1 2021

May 17, 2021
SELL
$19.92 - $31.6 $5.73 Million - $9.09 Million
-287,507 Reduced 86.83%
43,591 $1.33 Million
Q4 2020

Feb 17, 2021
SELL
$12.16 - $19.77 $135,717 - $220,652
-11,161 Reduced 3.26%
331,098 $6.55 Million
Q3 2020

Nov 16, 2020
BUY
$11.25 - $14.75 $297,270 - $389,754
26,424 Added 8.37%
342,259 $4.46 Million
Q2 2020

Aug 14, 2020
SELL
$10.69 - $16.49 $24,501 - $37,795
-2,292 Reduced 0.72%
315,835 $3.58 Million
Q1 2020

May 14, 2020
SELL
$9.78 - $29.53 $174,709 - $527,523
-17,864 Reduced 5.32%
318,127 $4.55 Million
Q4 2019

Feb 13, 2020
BUY
$20.93 - $35.1 $160,072 - $268,444
7,648 Added 2.33%
335,991 $9.15 Million
Q3 2019

Nov 14, 2019
BUY
$22.08 - $47.08 $3.57 Million - $7.61 Million
161,571 Added 96.88%
328,343 $9.53 Million
Q2 2019

Aug 13, 2019
BUY
$22.67 - $35.0 $384,800 - $594,090
16,974 Added 11.33%
166,772 $4.63 Million
Q1 2019

May 14, 2019
SELL
$26.93 - $34.7 $11,337 - $14,608
-421 Reduced 0.28%
149,798 $4.97 Million
Q4 2018

Feb 14, 2019
SELL
$27.23 - $45.56 $404,419 - $676,657
-14,852 Reduced 9.0%
150,219 $4.37 Million
Q3 2018

Nov 13, 2018
SELL
$37.57 - $50.34 $5.93 Million - $7.94 Million
-157,709 Reduced 48.86%
165,071 $7.59 Million
Q2 2018

Aug 14, 2018
SELL
$27.75 - $40.17 $1.78 Million - $2.58 Million
-64,304 Reduced 16.61%
322,780 $12.1 Million
Q1 2018

May 14, 2018
SELL
$28.83 - $41.01 $2.57 Million - $3.65 Million
-89,072 Reduced 18.71%
387,084 $11.4 Million
Q4 2017

Feb 14, 2018
SELL
$28.45 - $37.14 $322,765 - $421,353
-11,345 Reduced 2.33%
476,156 $16.4 Million
Q3 2017

Nov 14, 2017
SELL
$24.01 - $36.2 $602,170 - $907,896
-25,080 Reduced 4.89%
487,501 $17.6 Million
Q2 2017

Aug 14, 2017
BUY
N/A
512,581
512,581 $13.2 Million

Others Institutions Holding MYGN

# of Institutions
227
Shares Held
92M
Call Options Held
297K
Put Options Held
20.7K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track S&T Bank Portfolio

Follow S&T Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

News

Stay updated on S&T Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email